Why some rheumatoid arthritis patients respond poorly to biologics
Monday, November 14, 2016 - 17:51
in Health & Medicine
A new study is shedding light on why some rheumatoid arthritis patients respond poorly when treated with tumor necrosis factor inhibitors, part of a class of drugs called biologics.